Clinical Trials Directory

Trials / Completed

CompletedNCT06789874

To Compare the Efficacy of Intralesional Saline Versus 35% Trichloracetic Acid (TCA) Peel in the Treatment of Atrophic Acne Scars

Comparing the Efficacy of Intralesional Saline Versus 35% Trichloracetic Acid (TCA) Peel in the Treatment of Atrophic Acne Scars

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
126 (actual)
Sponsor
Sheikh Zayed Medical College · Other Government
Sex
All
Age
16 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This study aimed to compare the efficacy of intradermal normal saline versus trichloroacetic acid (TCA) in treating atrophic acne scars. Atrophic acne scars are a common and disfiguring complication, with limited research on the use of normal saline.

Detailed description

Acne vulgaris is a common skin problem affecting adolescents and adults. It is the eighth most common skin disease globally, having a prevalence ranging from 35%-85%, with notable variations across different regions and age groups.A randomized controlled trial was conducted at the Dermatology Department, Sheikh Zayed Hospital, Rahim Yar Khan, from 1st April 2023 to 31st October 2023. 126 patients were enrolled. Scar grading was based on Goodman and Baron's Qualitative Scar Classification. The Observer Scar Assessment Scale (OSAS) was used by dermatologists. Patients rated their acne scars using the Visual Disease Severity Scale. Photographs were taken for comparison. Efficacy was defined as ≥50% improvement in the OSAS.

Conditions

Interventions

TypeNameDescription
PROCEDUREIntralesional SalineIntralesional Saline injected in scars
PROCEDURE35% trichloracetic acid peel35%Trichloracetic acid peel was applied to scars monthly for 3 months

Timeline

Start date
2023-04-01
Primary completion
2023-06-30
Completion
2023-10-31
First posted
2025-01-23
Last updated
2025-01-23

Locations

2 sites across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06789874. Inclusion in this directory is not an endorsement.